We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmakers Join GPhA in Call for Same-Name Biosimilars
Lawmakers Join GPhA in Call for Same-Name Biosimilars
October 25, 2013
A bipartisan group of senators is aligning itself with GPhA in urging that biosimilars be allowed to share the same international non-proprietary name (INN) as the biologic drug they reference, to avoid confusion that could jeopardize patient safety and access.